Response Rate Is Associated with Prolonged Survival in Patients with Advanced Non-small Cell Lung Cancer Treated with Gefitinib or Erlotinib
暂无分享,去创建一个
A. Kubo | M. Takada | Y. Koh | T. Kurata | T. Kawaguchi | K. Tsujino | K. Nakao | S. Isa | K. Tachibana | N. Aono